Corpus ID: 37382491

Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

@article{Scheuch2007AnticoagulativeEO,
  title={Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.},
  author={G. Scheuch and P. Brand and T. Meyer and C. Herpich and B. Muellinger and J. Brom and G. Weidinger and M. Kohlh{\"a}ufl and K. Haeussinger and M. Spannagl and W. Schramm and R. Siekmeier},
  journal={Journal of physiology and pharmacology : an official journal of the Polish Physiological Society},
  year={2007},
  volume={58 Suppl 5 Pt 2},
  pages={
          603-14
        }
}
  • G. Scheuch, P. Brand, +9 authors R. Siekmeier
  • Published 2007
  • Medicine
  • Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
  • Inhalation of heparin results in local antiinflammatory and antifibrotic effects and an inhibition of blood coagulation. A number of experimental and clinical studies demonstrated that inhalant administration of heparin or low molecular weight heparin (LMWH) is a feasible and save tool for anticoagulative treatment. However, heparin and LMWH differ in respect to their molecular weight, pulmonary absorption, and principle of their anticoagulative pattern. In our study we investigated the… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    To evaluate the safety and efficacy of the use of inhalational heparin in patients with pulmonary compromise / pneumonia / SARS associated with COVID-19, laboratory with marked… Expand
    ConditionsCovid19, Pneumonia
    InterventionDrug
    Inhalational use of antithrombotics in humans: Review of the literature.
    • 7
    • Highly Influenced